Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,648   6.89  Index Moved Down -0.42%
BAX COV BDX BCR ISP Stores Plastics Healthcare Funds 
United States GSPC USD ...  |  Check Insiders


Processing
Processing. Please wait...

STAAR insider: Don Bailey

       

Don Bailey - STAAR Insider Profile

Independent Chairman of the Board

Mr. Don Bailey serves as Independent Chairman of the Board of STAAR Surgical Company. He has served as a Director and Chairman since April 2005, and serves as the chairman of the Nominating and Governance Committee of the Board of Directors. Since November 26, 2007, Mr. Bailey has served as President, Chief Executive Officer and a director of Questcor Pharmaceuticals, Inc., having served as its interim President from May 2007 and as a director since May 2006. In addition, he served as Chairman of the Board of Comarco, Inc., a provider of wireless test products for the wireless industry and a maker of emergency call box systems and mobile power products for handheld devices, from 1998 until August 31, 2007. He also served from June 1990 to April 2000 as President of Comarco, Inc. and as its Chief Executive Officer from January 1991 to April 2000
Age: 66  Chairman Since 2005  MBA    
626-303-7902  http://www.staar.com

Other Appointments

Questcor Pharmaceuticals IncQCORUnited States Nasdaq
CEO since 2007
STANLEY ELECTRIC COSTAAGermany Berlin
Chairman since 2005
STANLEY ELECTRIC COSTAAGermany Frankfurt
Chairman since 2005
Don Bailey EducationBailey earned his BS degree in Mechanical Engineering from Drexel University in 1968, his MS degree in Operations Research from the University of Southern California in 1971 and his MBA degree from Pepperdine University in 1986.

Management Efficency

The company has return on total asset (ROA) of 1.71 % which means that it generated profit of $1.71 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (5.76) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 7.17 M in liabilities with Debt to Equity (D/E) ratio of 0.23 which may suggest the company is not taking enough advantage from borrowing. STAAR Surgical Company has Current Ratio of 2.41 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
    

Other Executives

Barry Caldwell, CEO
Craig Felberg, President, MBA
Donald Todd, President
Paul Hambrick, President
Donald Fagen, President
Samuel Gesten, President
Hans-Martin Blickensdoerfer, President
Hideo Watanabe, President
William Goodmen, President
John Santos, President
Deborah Andrews, CFO
Richard Meier, Director
John Moore, Director
Mark Logan, Director
Charles Slacik, Director
Donald Duffy, Director, MBA
James Francese, VP, MBA
Samuel JD, VP
Philippe Subrin, VP
Robin Hughes, VP, MBA

Entity Summary

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures and sells implantable lenses for the eye. STAAR Surgical Company [STAA] is traded on NASDAQ General Markets in USA. It is located in Monrovia, CA and employs 301 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
STAA United States Nasdaq
STAAR Surgical Company
Benchmark S&P 500
Currency: USD - US Dollar
Traded on NASDAQ General Markets
    
    
Chance of
Bankruptcy
Less
Than
1%
In The Next
Two Years
STAAR Surgical Company has less than 1.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

STAAR price boundaries

    
May 01 2013
 6.94 
  
 6.55 
(0.39)  Macroaxis: -5.619596541786751 Down   5.62%  
Lowest period price (30 days)
May 13 2013
 9.04 
  
 9.25 
0.21  Macroaxis: 2.3230088495575316 Up   2.32%  
Highest period price (30 days)
    

Promote STAAR and Don Bailey

Follow STAAR with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add STAAR to your reader
 

Today Change

 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 thisGreen STAA STAA agains markets  0.00 % No Change  
 United States Russel   0.30 % Macroaxis: 0.3 Moved Down  
 
 United States SP 500   0.38 % Macroaxis: 0.38 Moved Down  
 
 United States NYSE   0.70 % Macroaxis: 0.7 Moved Down  
 

Stock Performance

Shares Outstanding36.64 M
Number of Shares Shorted1.38 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium